Il miglioramento dell insulino-resistenza un effetto chiave che collega gli impieghi terapeutici del farmaco: Nel diabete tipo 2 , leffetto incretinico corregge il difetto insulinico relativo e migliora il controllo glicemico
Lower maintenance doses may help maintain appetite control while patients focus on long-term habits such as exercise and balanced nutrition
[2] Treatment usually starts at 0.25 mg weekly for 4 weeks, then increases to 0.5 mg, with further titration to 1 mg or 2 mg if needed for glycaemic control
Liraglutide (Victoza): A Human GLP-1 Analog for Once-Daily Use Liraglutide is a modified human GLP-1 analog essentially, it has the same amino acid sequence as human GLP-1 (7-37) except for two modifications: an arginine substitution at one position and a C-16 fatty acid chain attached via a spacer to Lysine at position 26 ( [111] )
This matters because each point reduction significantly lowers your risk of diabetes complications
The discovery of GLP-1 and its role in blood sugar regulation and weight loss was more specifically a result of continuing research into gut hormones and their effects on metabolism